Overview

The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients

Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
0
Participant gender:
Female
Summary
Nausea and vomiting after surgery are one of the complications that occur after general anesthesia, and the frequency is reported to range from 10% to 80% in the high-risk group. Several studies have introduced drugs and methods to prevent nausea and vomiting after surgery. Among them, midazolam administered before surgery is known to have anti-anxiolytic and sedative effects on the prevention of nausea and vomiting after surgery. It has also been reported to increase its effectiveness when administered with other antiemetic agents. The purpose of this study is to compare the effects of administration of combination with midazolam and different antiemetic agents on the prevention of postoperative nausea and vomiting in high-risk patients.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Daegu Catholic University Medical Center
Treatments:
Midazolam
Palonosetron
Ramosetron
Criteria
Inclusion Criteria:

- 20-65 years old with American Society of Anesthesiologists (ASA) physical status 1-2
and scheduled for laparoscopic cholecystectomy.

Exclusion Criteria:

- pregnant or breast feeding patients

- smokers

- patients with history of chronic opioid abuse

- hypersensitivity to 5-HT3 receptor antagonists or analgesics

- those who were antiemetic or opioid treatment within 24 hours prior to surgery